| Mary Alyssa Wisnesky, MS, CCC-SLP | |
|
808 Ivy Way Apt 3a, Frederick, MD 21701-9264 | |
| (412) 452-6345 | |
| Not Available |
| Full Name | Mary Alyssa Wisnesky |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 808 Ivy Way Apt 3a, Frederick, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013623701 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 10244 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Alyssa Wisnesky, MS, CCC-SLP 808 Ivy Way Apt 3, Frederick, MD 21701-9263 Ph: (412) 452-6345 | Mary Alyssa Wisnesky, MS, CCC-SLP 808 Ivy Way Apt 3a, Frederick, MD 21701-9264 Ph: (412) 452-6345 |
News Archive
In 2006, researchers published a widely reported study showing that for many patients who had suffered a heart attack more than 24 hours before and had a blocked coronary artery, certain heart procedures, such as balloon angioplasty and the insertion of stents, were no more effective than drugs alone. In 2007, the American Heart Association and the American College of Cardiology issued guidelines urging doctors to not use such treatments in those patients.
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and inborn errors of metabolism (IEMs), today announced that new clinical data from the Phase 1 study of AG-221, an orally available, selective, potent inhibitor of the mutated IDH2 protein, will be highlighted in an oral presentation at the 19th Congress of the European Hematology Association (EHA) taking place June 12 -15, 2014 in Milan, Italy.
Scientists who recently identified the molecular start of Alzheimer's disease have used that finding to determine that it should be possible to forecast which type of dementia will develop over time - a form of personalized medicine for neurodegenerative diseases.
A stroke therapy using stem cells extracted from patients' bone marrow has shown promising results in the first trial of its kind in humans.
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Sharon D'Agostino, vice president of worldwide corporate contributions and community relations for Johnson & Johnson, reflects on the two-day Child Survival Call to Action held in mid-June, writing, "An estimated seven hundred people from around the world traveled to the event in Washington, D.C., all embracing the theme that every child deserves to have a 5th birthday, no matter where on this planet she or he is born."
› Verified 9 days ago
Ms. Linda B Pruce, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 W 7th St, Frederick, MD 21701 Phone: 240-566-3337 Fax: 240-566-4872 | |
Mrs. Heather Nicole Krumpe, MS/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11248 Alton Rd, Frederick, MD 21701 Phone: 443-904-6694 | |
Kourtney Alexis Murphy, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6980 Rooks Ct, Apt 201, Frederick, MD 21703 Phone: 240-418-4603 | |
Matthew Lalli, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 Waverley Dr, Frederick, MD 21702 Phone: 240-236-3900 | |
Laurel Mackereth, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6403 Mill Run Ct, Frederick, MD 21703 Phone: 301-639-5450 | |
Victoria Carey, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9093 Ridgefield Dr Ste 102, Frederick, MD 21701 Phone: 301-846-4769 Fax: 301-846-0059 |